Abhishek Srivastava
Net worth: 145 $ as of 2024-03-30
Profile
Abhishek Srivastava is currently working as Vice President-Technical Operations at Alaunos Therapeutics, Inc. He previously worked as Vice President-Cell Therapy Development at Athenex, Inc. He holds a doctorate degree from the University of Louisville School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-14 | 80 ( 0.00% ) | 145 $ | 2024-03-30 |
Former positions of Abhishek Srivastava
| Companies | Position | End |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-09-30 |
| ATHENEXPAR | Corporate Officer/Principal | - |
Training of Abhishek Srivastava
| University of Louisville School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- Abhishek Srivastava
